113 related articles for article (PubMed ID: 10517216)
1. A molecular and clinical study of heterozygous familial hyplercholesterolemia in the Finnish North Karelia.
Vuorio A
Scand Cardiovasc J; 1999; 33(4):252-3. PubMed ID: 10517216
[No Abstract] [Full Text] [Related]
2. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
3. "Finnish" mutations in LDL receptor gene: a rare cause of familial hypercholesterolemia in St. Petersburg and Petrozavodsk.
Komarova TY; Golovina AS; Grudinina NA; Zakharova FM; Korneva VA; Lipovetskii BM; Serebrenitskaya MP; Konstantinov VO; Vasilyev VB; Mandelshtam MY
Bull Exp Biol Med; 2013 Jul; 155(3):380-3. PubMed ID: 24137609
[TBL] [Abstract][Full Text] [Related]
4. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
Koivisto UM; Turtola H; Aalto-Setälä K; Top B; Frants RR; Kovanen PT; Syvänen AC; Kontula K
J Clin Invest; 1992 Jul; 90(1):219-28. PubMed ID: 1634609
[TBL] [Abstract][Full Text] [Related]
5. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.
Vuorio AF; Turtola H; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3332-7. PubMed ID: 9409330
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia.
Lind S; Eriksson M; Rystedt E; Wiklund O; Angelin B; Eggertsen G
J Intern Med; 1998 Jul; 244(1):19-25. PubMed ID: 9698020
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
8. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
9. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.
Vohl MC; Szots F; Lelièvre M; Lupien PJ; Bergeron J; Gagné C; Couture P
Atherosclerosis; 2002 Feb; 160(2):361-8. PubMed ID: 11849659
[TBL] [Abstract][Full Text] [Related]
10. Identification of a deletion in the LDL receptor gene. A Finnish type of mutation.
Aalto-Setälä K; Gylling H; Miettinen T; Kontula K
FEBS Lett; 1988 Mar; 230(1-2):31-4. PubMed ID: 2895023
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene.
Kontula K; Koivisto UM; Koivisto P; Turtola H
Ann Med; 1992 Oct; 24(5):363-7. PubMed ID: 1418919
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects.
Ferrières J; Sing CF; Roy M; Davignon J; Lussier-Cacan S
Arterioscler Thromb; 1994 Oct; 14(10):1553-60. PubMed ID: 7918304
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
[TBL] [Abstract][Full Text] [Related]
14. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group.
Vuorio AF; Aalto-Setälä K; Koivisto UM; Turtola H; Nissen H; Kovanen PT; Miettinen TA; Gylling H; Oksanen H; Kontula K;
Ann Med; 2001 Sep; 33(6):410-21. PubMed ID: 11585102
[TBL] [Abstract][Full Text] [Related]
15. [Gene mutations in familial hyperlipidemias].
Yamamoto A
Nihon Rinsho; 2001 Feb; 59 Suppl 2():661-9. PubMed ID: 11351667
[No Abstract] [Full Text] [Related]
16. A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes.
Ward AJ; O'Kane M; Nicholls DP; Young IS; Nevin NC; Graham CA
Atherosclerosis; 1996 Feb; 120(1-2):83-91. PubMed ID: 8645375
[TBL] [Abstract][Full Text] [Related]
17. [Finnish type mutations leading to heart disorders].
Kontula K
Duodecim; 2005; 121(24):2665-79. PubMed ID: 16454248
[No Abstract] [Full Text] [Related]
18. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
19. [Recent trend in the research of hyperlipidemia in Japan (2). Molecular genetics and clinical features of familial hypercholesterolemia].
Mabuchi H
Nihon Naika Gakkai Zasshi; 1989 Oct; 78(10):1402-5. PubMed ID: 2600495
[No Abstract] [Full Text] [Related]
20. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
Miltiadous G; Cariolou MA; Elisaf M
Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
